NASDAQ

Xenetic Biosciences, Inc. (XBIO)

315 Thanks from members

Xenetic Biosciences, Inc. (XBIO) demonstrates mixed market sentiment with a micro-cap valuation of ~$5.81M, supported by a healthy balance sheet holding more cash than debt, contrasted against ongoing legal expenses, operating losses, and a strategic review process.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →